|
QuickStats: Prevalence of Antihypertensive Medication Use* During
the Preceding Month Among Persons with
Hypertension† Aged >18 Years,
by Race/Ethnicity --- United States, 1988--1994 and 1999--2002
* Specific prescription antihyperstensive medications were identified from an inventory of all prescription medications
used during the 1-month period before the interview.
† Persons with systolic blood pressure
>140 mm Hg or diastolic blood pressure
>90 mm Hg or who reported current use of a prescription medication for high blood pressure.
The prevalence of antihypertensive medication use during the preceding month among
adults with hypertension increased from 57% in 1988--1994 to nearly 63% in 1999--2002.
Substantial increases in use also occurred among non-Hispanic white and black adults but not
among Mexican-Americans, for whom prevalence remained at approximately 40%.
SOURCE: Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults
with hypertension. Circulation 2006;113:213--21.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication. |
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
Date last reviewed: 5/25/2006
|
